Journal of Precision Medicine and Genomic Therapeutics

About Journal

The rapid expansion of genomic science has transformed modern medicine, offering new possibilities for diagnosis, treatment selection, and disease prevention. As researchers and clinicians seek to individualise care based on genetic, molecular, and environmental profiles, a growing body of work now falls under the domain of precision medicine. The Journal of Precision Medicine and Genomic Therapeutics has been established to provide a peer-reviewed platform for the publication of research that contributes to this evolving field. The journal focuses on the clinical, translational, and therapeutic dimensions of precision-based approaches to human health.

This journal supports the integration of genomics, bioinformatics, pharmacogenomics, molecular diagnostics, and personalised treatment design. It is intended for scientists, medical professionals, genetic counsellors, pharmacologists, data scientists, and health system researchers who are contributing to the development or application of precision medicine in clinical care or population health.

The Journal of Precision Medicine and Genomic Therapeutics welcomes original research, review articles, translational case studies, clinical implementation reports, and early-phase therapeutic trials. The journal encourages contributions that explore how genomic insights are applied to decision-making in real clinical settings. It also accepts articles that address the broader system-level and ethical implications of adopting precision-based strategies in medicine.

The journal supports a wide range of subjects related to precision health and therapeutic innovation. These include:

• Genomic profiling and its use in disease risk stratification
• Pharmacogenomic testing for drug selection and dosing
• Molecular diagnostics for cancer, rare disease, and inherited conditions
• Development and validation of genomic biomarkers
• RNA-based therapeutics and antisense oligonucleotide strategies
• CRISPR and gene-editing approaches in therapeutic design
• Targeted therapies guided by tumour genomics
• Integration of omics data in clinical trial design
• Machine learning in genomic data interpretation
• Personalised treatment pathways for complex chronic conditions
• Ethical frameworks for genetic data use in precision care
• Implementation science in genomic medicine rollouts
• Digital tools supporting personalised treatment plans
• Infrastructure development for genomic data sharing and interoperability

The Journal of Precision Medicine and Genomic Therapeutics values contributions that bridge the gap between discovery and application. Authors are encouraged to submit manuscripts that provide insight into how genetic information, molecular pathways, or bioinformatic tools are used to guide diagnosis or treatment in clinical practice. Research that describes how precision medicine models are adapted for local or population-specific use is of particular interest, especially in resource-limited or emerging settings.

The journal recognises that precision medicine does not function in isolation. It is influenced by policy, equity, access to testing, data interpretation capabilities, and clinician readiness. As such, the journal is open to submissions that examine how healthcare systems adopt precision approaches, how patients understand and respond to genomic information, and how ethical standards are upheld in the collection and use of personal genetic data.

All manuscripts submitted to the Journal of Precision Medicine and Genomic Therapeutics undergo double-blind peer review. Reviewers are selected based on relevant expertise in precision health, genetics, molecular biology, data science, or clinical medicine. Each submission is evaluated for scientific accuracy, originality, translational value, and clarity of presentation. Authors are provided with detailed feedback and, if appropriate, given the opportunity to revise their work prior to acceptance.

Manuscripts may be submitted in the following formats:

• Original research articles
• Review and synthesis papers
• Translational case studies
• Clinical trial reports (early phase or exploratory trials)
• Implementation studies of genomic tools in practice
• Perspective and commentary pieces on genomic policy or access
• Methodological papers describing validation or standardisation processes
• Reports on platform development or informatics integration

Submissions may involve any clinical specialty, including oncology, neurology, cardiology, infectious disease, endocrinology, paediatrics, or reproductive medicine, provided the manuscript includes a clear connection to precision or genomic science.

Authors must ensure that all manuscripts meet appropriate ethical standards. For clinical research involving patient participation or identifiable genetic data, approval from a recognised ethics committee must be stated clearly. Manuscripts must protect the privacy and confidentiality of patients, especially when genomic or familial information is included. When patient images or narratives are used, consent must be obtained and documented.

The journal encourages the submission of supplementary materials where relevant. Authors may provide additional datasets, bioinformatics pipelines, code repositories, or visualisations that support reproducibility and transparency. Details for accessing these materials should be included within the manuscript or as part of a supplementary file.

Submissions are welcomed from academic institutions, clinical research units, translational research centres, biotechnology companies, and public health organisations. The journal supports global participation and encourages submissions that reflect precision medicine applications in both high- and low-resource settings. Case reports or data series from underrepresented populations are of interest, especially when the findings suggest new directions for personalised care.

The Journal of Precision Medicine and Genomic Therapeutics requires that all references cited in the text be listed at the end of the manuscript. The journal accepts citations in APA style. Authors must ensure accuracy and consistency in referencing.

An Article Processing Charge will be levied upon acceptance of the manuscript. The editorial office will provide full details to the corresponding author at the time of acceptance.

This journal operates under an open-access model. All published content will be freely available to readers worldwide, ensuring that advances in precision medicine can be shared, discussed, and implemented across borders and institutions.

The Journal of Precision Medicine and Genomic Therapeutics serves as a venue for rigorous, clinically relevant, and ethically responsible research in one of the most rapidly advancing fields of modern healthcare. Through its focus on genomic science, personalised treatment, and translational application, the journal seeks to accelerate the transition from scientific insight to patient benefit.